Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy

Fig. 3

Plasma Aβ38, Aβ40, and Aβ42 levels in patients with sCAA and controls. Scatter plots in all panels (depicting median and interquartile range). p-values are adjusted for age and sex. A Plasma Aβ38 levels were similar in sCAA patients versus controls (p = 0.092). B Plasma Aβ40 levels were similar in sCAA patients and controls (p = 0.64). C Plasma Aβ42 levels were similar in sCAA patients and controls (p = 0.68). Abbreviations: sCAA, sporadic cerebral amyloid angiopathy Ns, non-significant

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193